These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36233293)

  • 1. Interaction of MRPL9 and GGCT Promotes Cell Proliferation and Migration by Activating the MAPK/ERK Pathway in Papillary Thyroid Cancer.
    Zhang HM; Li ZY; Dai ZT; Wang J; Li LW; Zong QB; Li JP; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-205-5p/GGCT Attenuates Growth and Metastasis of Papillary Thyroid Cancer by Regulating CD44.
    Li HN; Zhang HM; Li XR; Wang J; Xu T; Li SY; Dong ML; Wang G; Cui XQ; Yang X; Wu YL; Liao XH; Du YY
    Endocrinology; 2022 Apr; 163(4):. PubMed ID: 35213720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of ANXA10 inhibits proliferation and promotes apoptosis of papillary thyroid carcinoma cells by down-regulating TSG101 thereby inactivating the MAPK/ERK signaling pathway.
    Wei T; Zhu X
    J Bioenerg Biomembr; 2021 Aug; 53(4):429-440. PubMed ID: 34032966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semaphorin 3D inhibits proliferation and migration of papillary thyroid carcinoma by regulating MAPK/ERK signaling pathway.
    Hai R; You Q; Wu F; Qiu G; Yang Q; Shu L; Xie L; Zhou X
    Mol Biol Rep; 2022 May; 49(5):3793-3802. PubMed ID: 35190928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
    Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
    J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway.
    Hu X; Chen S; Xie C; Li Z; Wu Z; You Z
    J Endocrinol Invest; 2021 Aug; 44(8):1609-1623. PubMed ID: 33387351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
    Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
    Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
    Yu ST; Zhong Q; Chen RH; Han P; Li SB; Zhang H; Yuan L; Xia TL; Zeng MS; Huang XM
    Cell Death Dis; 2018 Mar; 9(3):371. PubMed ID: 29515111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.
    Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B
    Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
    Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLP-2 regulates the generation of reactive oxygen species and the ERK pathway to promote papillary thyroid carcinoma motility and angiogenesis.
    Chen J; Wang D; Xu R; Yao T; Guo Y; Liu Q; Yang E; Wu Z; Xu Z
    Tissue Cell; 2023 Feb; 80():101997. PubMed ID: 36527788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway.
    Liao T; Wen D; Ma B; Hu JQ; Qu N; Shi RL; Liu L; Guan Q; Li DS; Ji QH
    Oncotarget; 2017 Feb; 8(7):11719-11728. PubMed ID: 28036290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating PTEN.
    Guo K; Wang J; Shu L; Zhou G
    Tissue Cell; 2021 Dec; 73():101647. PubMed ID: 34543800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. γ-Glutamylcyclotransferase Knockdown Inhibits Growth of Lung Cancer Cells Through G0/G1 Phase Arrest.
    Lin Z; Xiong L; Zhou J; Wang J; Li Z; Hu H; Lin Q
    Cancer Biother Radiopharm; 2015 Jun; 30(5):211-6. PubMed ID: 25941902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetraspanin 1 regulates papillary thyroid tumor growth and metastasis through c-Myc-mediated glycolysis.
    Han J; Xie C; Liu B; Wang Y; Pang R; Bi W; Sheng R; He G; Kong L; Yu J; Ding Z; Chen L; Jia J; Zhang J; Nie C
    Cancer Sci; 2023 Dec; 114(12):4535-4547. PubMed ID: 37750019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
    Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
    Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-877 inhibits the proliferation, migration, and invasion of osteosarcoma cells by targeting gamma-glutamylcyclotransferase.
    Jia C; Gao J; Wang L; Li Z; Dong Z; Yao L; Yao X
    Endocr J; 2021 Sep; 68(9):1109-1116. PubMed ID: 34121038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SRPX2 promotes cancer cell proliferation and migration of papillary thyroid cancer.
    Guo H; Liu R; Wu J; Li S; Yao W; Xu J; Zheng C; Lu Y; Zhang H
    Clin Exp Med; 2023 Dec; 23(8):4825-4834. PubMed ID: 37306872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.